# EDGAR Filing Document

**Accession Number:** 0000806172
**File Stem:** 0001171520-25-000317
**Filing Date:** 2025-10
**Character Count:** 7924
**Document Hash:** c81ef50dc95777442b3af5ded2b99bc2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001171520-25-000317.hdr.sgml**: 20251014

**ACCESSION NUMBER**: 0001171520-25-000317

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20251013

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251014

**DATE AS OF CHANGE**: 20251014

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SONO TEK CORP
- **CENTRAL INDEX KEY:** 0000806172
- **STANDARD INDUSTRIAL CLASSIFICATION:** SPECIAL INDUSTRY MACHINERY, NEC [3559]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 141568099
- **STATE OF INCORPORATION:** NY
- **FISCAL YEAR END:** 0228

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40763
- **FILM NUMBER:** 251389595

**BUSINESS ADDRESS:**
- **STREET 1:** 2012 RT 9W BLDG 3
- **CITY:** MILTON
- **STATE:** NY
- **ZIP:** 12547
- **BUSINESS PHONE:** 8457952020

**MAIL ADDRESS:**
- **STREET 1:** 2012 RT. 9W, BLDG. 3,
- **CITY:** MILTON
- **STATE:** NY
- **ZIP:** 12547

?xml version='1.0' encoding='ASCII'?

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

**FORM 8-K**

**CURRENT REPORT**

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): **October 13, 2025**

**<u>Sono-Tek Corporation</u>**

(Exact name of registrant as specified in its charter)

Commission File Number: **001-40763**

---

| | |
|:---|:---|
| **<u>New York</u>** | **<u>14-1568099</u>** |
| (State of Incorporation) | (I.R.S. Employer ID No.) |
| **<u>2012 Route 9W, Milton, New York</u>** | **<u>12547</u>** |
| (Address of Principal Executive Offices) | (Zip Code) |

---

Registrant's telephone number, including area code: **(845) 795-2020**

Check appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **<u>Title of each class</u>** | **Trading**<br> **<u>Symbol(s)</u>** | **<u>Name of each exchange on which registered</u>** |
| Common Stock, $0.01 par value per share | SOTK | NASDAQ |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 2.02: Results of Operations and Financial Condition.**

**Item 7.01: Regulation FD Disclosure**

On October 13, 2025, Sono-Tek Corporation issued a press regarding an order for medical device coating systems valued at $2.8 Million which is attached as exhibit 99.1.

The information furnished pursuant to Item 2.02 and Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities under such section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.

**Item 9.01: Financial Statements and Exhibits.**

(d) Exhibits

99.1 &nbsp;&nbsp;&nbsp;&nbsp; [Press release dated October 13, 2025](ex99-1.htm)

104&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cover Page Interactive Data File (embedded within the Inline XBRL document)

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SONO-TEK CORPORATION

By: <u>/s/ Stephen J. Bagley</u>

Stephen J. Bagley

Chief Financial Officer

October 13, 2025

## Exhibit 99.1

Exhibit 99.1

**Sono-Tek Wins $2.8 Million Order for Advanced Medical Device Coating Systems**

MILTON, N.Y., October 13, 2025 - Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that it has received a purchase order valued at over $2.8 million from a major U.S.based medical device manufacturer.

This order, placed by an existing customer which is ramping up production, includes multiple advanced ExactaCoat MD (Medical Device) systems. The Exacoat MD systems include expanded capabilities compared to Sono-Tek's previously supplied equipment. These new systems will be installed in addition to the customer's existing Sono-Tek coating equipment, which will remain in production use. Deliveries of the new equipment are expected to begin in the beginning of calendar year 2026 and be completed within the first half of 2026.

Steve Harshbarger, President and CEO of Sono-Tek, commented:

"This award highlights the continued trust leading medical device manufacturers place in Sono-Tek as they scale production of innovative healthcare technologies. The addition of these higher-capability systems, complementing the Sono-Tek equipment already in use at this facility, underscores the value of our long-term customer relationships and the scalability of our coating platforms. Importantly, this order comes from a different customer than the $5 million medical device order we announced last month, further broadening our base of high-value opportunities."

This win reinforces Sono-Tek's strong position in the medical device sector, a critical growth driver in the Company's long-term strategy, and underscores its ability to capture repeat, multi-million-dollar orders from multiple leading manufacturers across the industry.

About Sono-Tek

Sono-Tek Corporation is the global leader in the design and manufacture of ultrasonic coating systems that are shaping industries and driving innovation worldwide. Our ultrasonic coating systems are used to apply thin films onto parts used in diverse industries including microelectronics, alternative energy, medical devices, advanced industrial manufacturing, and research and development sectors worldwide. Sono-Tek's inroads into the clean energy sector are showing transformative results in next-gen solar cells, fuel cells, green hydrogen generation, and carbon capture applications.

Our product line is rapidly evolving, transitioning from R&D to high-volume production machines with significantly higher average selling prices, showcasing our market leadership and adaptability. Our comprehensive suite of thin film coating solutions and application consulting services are expected to generate unparalleled results for our clients and help some of the world's most promising companies achieve technological breakthroughs and bring them to the market. We strategically deliver our products to customers through a network of direct sales personnel, carefully chosen independent distributors, and experienced sales representatives, ensuring efficient market reach across diverse sectors around the globe.

**For more information:**

**Sono-Tek Corp.** 

Stephen J. Bagley

Chief Financial Officer

Ph: (845) 795-2020

info@sono-tek.com

**Investor Relations**

Kirin Smith

PCG Advisory, Inc.

ksmith@pcgadvisory.com